UBRELVY
Generic: ubrogepant
- Manufacturer
- AbbVie
- NDC
- 0023-6501
- RxCUI
- 2268221
- Route
- ORAL
- ICD-10 indication
- G43.9
Affordability Check
How much will you actually pay for UBRELVY?
In 30 seconds, see every legitimate way to afford UBRELVY — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About UBRELVY
What is this medication? UBRELVY is a prescription medication used for the acute treatment of migraine headaches with or without aura in adults. It belongs to a class of drugs known as calcitonin gene-related peptide receptor antagonists, which are designed to target the specific biological pathways involved in migraine attacks. This medication is intended to be taken at the onset of a migraine to help alleviate pain and other symptoms rather than being used as a daily preventive measure.
The medication works by blocking a protein called CGRP from binding to its receptors in the brain, a process that is believed to play a major role in the development of migraine pain. By interfering with this protein, the drug helps to stop the migraine process once it has started. Common side effects can include nausea and sleepiness, and it is important for patients to discuss their medical history and any other medications they are taking with a healthcare provider before starting treatment.
Copay & patient assistance
- Patient Copay Amount: As little as $0 per monthly prescription fill.
- Maximum Annual Benefit Limit: $7,000 per calendar year.
- Core Eligibility Restrictions: Patients must be 18 years of age or older; must have commercial insurance; not valid for patients enrolled in federal, state, or government-funded insurance programs (e.g., Medicare, Medicaid, TRICARE, VA); not valid for cash-paying patients; must reside in the USA or Puerto Rico.
- RxBIN, PCN, and Group numbers: Not Publicly Available.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for ubrogepant.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup UBRELVY →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for ubrogepant →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How UBRELVY appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
66%
3,620 of 5,499 plans
Most common tier
Tier 3
On 61% of covering formularies
Prior authorization required
98%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 52 | 21% |
| Tier 2 (generic) | 10 | 4% |
| Tier 3 (preferred brand) | 153 | 61% |
| Tier 4 (non-preferred brand) | 2 | 1% |
| Tier 5 (specialty) | 35 | 14% |
Step therapy: 0% of formularies
Quantity limits: 97% of formularies
Coverage breadth: 252 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Treximet
Treats same condition · Sumatriptan Succinate and Naproxen Sodium
FROVATRIPTAN
Treats same condition · Frovatriptan succinate
Rizatriptan Benzoate ODT
Treats same condition · Rizatriptan Benzoate ODT
Relpax
Treats same condition · eletriptan hydrobromide
Topamax
Treats same condition · topiramate
Eletriptan Hydrobromide
Treats same condition · Eletriptan Hydrobromide
Naratriptan
Treats same condition · Naratriptan
Divalproex Sodium ER
Treats same condition · Divalproex Sodium ER
QUDEXY XR
Treats same condition · Topiramate
Trubrexa
Treats same condition · lidocaine and capsaicin
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.